View our list of available Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) antibodies, recombinant proteins, ELISA Kits... Options Full Datasheet Printer Friendly Datasheet Prepare for Printing Full Datasheet Printer Friendly Datasheet Prepare for Printing Have Questions? Ask Us! Request A Quote Today! Add To Compare List VARICELLA ZOSTER VIRUS Antigen Catalog # MBS239122 Unit / Price 1 mL / $665 +1 FREE 8GB USB 5x1 mL / $2,800 +3 FREE 8GB USB Product Name Product Info Accession #s Product Desc Diseases/Tissues/Pathways Applications References Product Name VARICELLA ZOSTER VIRUS, Antigen Full Product Name NATIVE VARICELLA ZOSTER VIRUS Research Use Only For Research Use Only. Not for use in diagnostic procedures. TOP Form/Format Inactivated PathogenInactivated Varicella zoster virus Concentration Approximate Protein Concentration: 1.17 mg/ml (lot specific) Source Varicella zoster virus, VZ-10 strain, cultured in MRC-5 cells.Preparation Buffer Solution Eagle's Minimum Essential Medium (MEM) Activity This product has been rendered inactive by standard procedures. However this material should still be handled as infectious and should be disposed of appropriately. Target Species Viral Preparation and Storage Store at -70 degree C. Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein.Shelf Life: 18 months from date of despatch. Other Notes Small volumes of VARICELLA ZOSTER VIRUS antigen vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply. TOP Related Product Information for VARICELLA ZOSTER VIRUS antigen Varicella zoster virus is a member of the herpesvirus family. It commonly causes chickenpox in children and shingles and postherpetic neuralgia in adults. Chickenpox is a common childhood disease characterised by a vesicular skin rash, becoming itchy pockmarks which eventually heal, mostly without scarring. The disease has a 10-21 day incubation period and is easily spread through coughs and sneezes or direct contact with secretions from the rash. The disease is rare, but generally more serious, in adults. The primary outbreak usually confers lifelong protective immunity, however, the virus can go on to cause shingles, a completely different disease, many years after a chickenpox outbreak. Shingles is characterised by a painful skin rash in a limited area on the body. The rash normally heals within two to four weeks, but some individuals may suffer from postherpetic neuralgia, or nerve pain, for months or years to follow. MBS239122 contains a high concentration of virus and viral components as well as some cellular material suspended in EMEM with some serum proteins. Applications Tested/Suitable for VARICELLA ZOSTER VIRUS antigen ELISA (EIA) TOP Precautions All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines. Disclaimer While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information. TOP